Search

Raymond J. Henley Iii

Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )

Most Active Art Unit
1614
Art Unit(s)
1205, 2899, 1629, 1614, 1621
Total Applications
4324
Issued Applications
3034
Pending Applications
603
Abandoned Applications
710

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 2895387 [patent_doc_number] => 05183814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-02 [patent_title] => 'Selective oestrogen therapy for perimenopausal or postmenopausal conditions' [patent_app_type] => 1 [patent_app_number] => 7/362043 [patent_app_country] => US [patent_app_date] => 1989-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5608 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/183/05183814.pdf [firstpage_image] =>[orig_patent_app_number] => 362043 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/362043
Selective oestrogen therapy for perimenopausal or postmenopausal conditions Jun 5, 1989 Issued
07/361520 METHOD FOR TREATING PERIPHERAL ATHEROSCLEROTIC DISEASE EMPLOYING AN HMG COA REDUCTASE INHIBITOR AND/OR A SQUALENE SYNTHETASE INHIBITOR Jun 4, 1989 Abandoned
Array ( [id] => 2748867 [patent_doc_number] => 05021424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-06-04 [patent_title] => 'Vitamin composition for treatment of flea infestation in animals' [patent_app_type] => 1 [patent_app_number] => 7/359957 [patent_app_country] => US [patent_app_date] => 1989-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4131 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/021/05021424.pdf [firstpage_image] =>[orig_patent_app_number] => 359957 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/359957
Vitamin composition for treatment of flea infestation in animals May 31, 1989 Issued
Array ( [id] => 2695219 [patent_doc_number] => 04988497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-01-29 [patent_title] => 'Process for the optical determination of lipase' [patent_app_type] => 1 [patent_app_number] => 7/353098 [patent_app_country] => US [patent_app_date] => 1989-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/988/04988497.pdf [firstpage_image] =>[orig_patent_app_number] => 353098 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/353098
Process for the optical determination of lipase May 16, 1989 Issued
Array ( [id] => 2705958 [patent_doc_number] => 05001116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-19 [patent_title] => 'Inhibition of angiogenesis' [patent_app_type] => 1 [patent_app_number] => 7/353213 [patent_app_country] => US [patent_app_date] => 1989-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6154 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/001/05001116.pdf [firstpage_image] =>[orig_patent_app_number] => 353213 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/353213
Inhibition of angiogenesis May 16, 1989 Issued
07/352253 COMPOSITION CONTAINING DIVALENT MANGANESE ION AND METHOD FOR PREPARING THE SAME May 15, 1989 Abandoned
Array ( [id] => 2644403 [patent_doc_number] => 04895715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-23 [patent_title] => 'Method of treating gynecomastia' [patent_app_type] => 1 [patent_app_number] => 7/351261 [patent_app_country] => US [patent_app_date] => 1989-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2586 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/895/04895715.pdf [firstpage_image] =>[orig_patent_app_number] => 351261 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/351261
Method of treating gynecomastia May 8, 1989 Issued
Array ( [id] => 2669682 [patent_doc_number] => 05070105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-03 [patent_title] => 'Stabilized antimicrobial compositions' [patent_app_type] => 1 [patent_app_number] => 7/346724 [patent_app_country] => US [patent_app_date] => 1989-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7964 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/070/05070105.pdf [firstpage_image] =>[orig_patent_app_number] => 346724 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/346724
Stabilized antimicrobial compositions May 2, 1989 Issued
07/346494 METHODS FOR TREATING ANXIETY WITH SIGMA RECEPTOR LIGANDS May 1, 1989 Abandoned
07/346340 PERFLUOROINDANE AS A GAS TRANSPORT AGENT IN ANIMALS Apr 27, 1989 Abandoned
07/341900 THERAPEUTIC CHOLESTEROL GALLSTONE DISSOLUTION METHOD Apr 23, 1989 Abandoned
Array ( [id] => 2769177 [patent_doc_number] => 05075116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-24 [patent_title] => 'Composition and method for treatment of macular degeneration' [patent_app_type] => 1 [patent_app_number] => 7/341025 [patent_app_country] => US [patent_app_date] => 1989-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4226 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/075/05075116.pdf [firstpage_image] =>[orig_patent_app_number] => 341025 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/341025
Composition and method for treatment of macular degeneration Apr 19, 1989 Issued
Array ( [id] => 2748707 [patent_doc_number] => 05030630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-09 [patent_title] => 'Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone' [patent_app_type] => 1 [patent_app_number] => 7/338690 [patent_app_country] => US [patent_app_date] => 1989-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1519 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/030/05030630.pdf [firstpage_image] =>[orig_patent_app_number] => 338690 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/338690
Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone Apr 16, 1989 Issued
07/337935 SPECTRAL DIAGNOSIS OF DISEASED TISSUE Apr 13, 1989 Abandoned
Array ( [id] => 2705921 [patent_doc_number] => 05061477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-10-29 [patent_title] => 'Use of cobalt to enhance urinary copper excretion' [patent_app_type] => 1 [patent_app_number] => 7/336681 [patent_app_country] => US [patent_app_date] => 1989-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4260 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/061/05061477.pdf [firstpage_image] =>[orig_patent_app_number] => 336681 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/336681
Use of cobalt to enhance urinary copper excretion Apr 10, 1989 Issued
07/334892 SHORT-CHAIN TRIGLYCERIDES Apr 6, 1989 Abandoned
Array ( [id] => 2521643 [patent_doc_number] => 04873076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-10-10 [patent_title] => 'Method of safely providing anesthesia or conscious sedation' [patent_app_type] => 1 [patent_app_number] => 7/333321 [patent_app_country] => US [patent_app_date] => 1989-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2130 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/873/04873076.pdf [firstpage_image] =>[orig_patent_app_number] => 333321 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/333321
Method of safely providing anesthesia or conscious sedation Apr 5, 1989 Issued
Array ( [id] => 2524552 [patent_doc_number] => 04883821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-11-28 [patent_title] => 'Agent for treating hyperuricemia' [patent_app_type] => 1 [patent_app_number] => 7/332011 [patent_app_country] => US [patent_app_date] => 1989-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1847 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/883/04883821.pdf [firstpage_image] =>[orig_patent_app_number] => 332011 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/332011
Agent for treating hyperuricemia Mar 30, 1989 Issued
Array ( [id] => 2782241 [patent_doc_number] => 05087623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-02-11 [patent_title] => 'Chromic picolinate treatment' [patent_app_type] => 1 [patent_app_number] => 7/326590 [patent_app_country] => US [patent_app_date] => 1989-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 5158 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/087/05087623.pdf [firstpage_image] =>[orig_patent_app_number] => 326590 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/326590
Chromic picolinate treatment Mar 20, 1989 Issued
Array ( [id] => 2790724 [patent_doc_number] => 05143732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-01 [patent_title] => 'Orally administered pharmaceutical agent for iron and magnesium substitutive therapy' [patent_app_type] => 1 [patent_app_number] => 7/323993 [patent_app_country] => US [patent_app_date] => 1989-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1676 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/143/05143732.pdf [firstpage_image] =>[orig_patent_app_number] => 323993 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/323993
Orally administered pharmaceutical agent for iron and magnesium substitutive therapy Mar 14, 1989 Issued
Menu